A new study out of St. Michael’s Hospital’s MAP Centre for Urban Health Solutions found that distributing essential medicines at no charge to patients resulted…
Read More
Statins could protect older patients from severe pneumonia, study finds
Statins could be used to treat older patients admitted to hospital with a severe type of pneumonia, researchers at the University of Birmingham have found….
Read More
Nearly 3 in 10 Philadelphians know someone who’s died from opioid use, Pew survey finds
In a stark illustration of the depths of Philadelphia’s opioid crisis, a new survey of city residents found that nearly a third—29% – know someone…
Read More
Boom in overdose-reversing drug is tied to fewer drug deaths
Prescriptions of the overdose-reversing drug naloxone are soaring, and experts say that could be a reason overdose deaths have stopped rising for the first time…
Read More
Researchers find widespread aspirin use despite few benefits, high risks
Medical consensus once supported daily use of low dose aspirin to prevent heart attack and stroke in people at increased risk for cardiovascular disease (CVD)….
Read More
Prescribed opioids associated with overdose risk for family members without prescriptions
According to the Centers for Disease Control and Prevention, opioid overdoses were responsible for more than 42,000 deaths in 2016. Access to family members’ drugs…
Read More
Shedding light on ‘black box’ of inpatient opioid use
People who receive opioids for the first time while hospitalized have double the risk of continuing to receive opioids for months after discharge compared with…
Read More
‘Ecstasy’ shows promise for post-traumatic stress treatment
An international study involving researchers from UBC Okanagan has shown that MDMA, also known as ecstasy, may be a valuable tool for treating post-traumatic stress…
Read More
Short-term use of opioids increases subjective pleasure
The human opioid system contributes to the regulation of emotions, pleasure and pain. Opioids are strong analgesics. In addition to effectively relieving pain, external opioids…
Read More
Avelumab and axitinib approved for treatment of renal cell carcinoma
(HealthDay)—Avelumab (BAVENCIO) was approved this week for first-line treatment of advanced renal cell carcinoma (RCC) in combination with axitinib, the U.S. Food and Drug Administration…
Read More